227 related articles for article (PubMed ID: 28339086)
1. Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.
Chang YS; Huang HD; Yeh KT; Chang JG
Int J Oncol; 2017 May; 50(5):1778-1784. PubMed ID: 28339086
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in endometrial cancer by targeted next-generation sequencing.
Chang YS; Huang HD; Yeh KT; Chang JG
Exp Mol Pathol; 2016 Feb; 100(1):8-12. PubMed ID: 26626801
[TBL] [Abstract][Full Text] [Related]
3. Next-Generation Sequencing.
Le Gallo M; Lozy F; Bell DW
Adv Exp Med Biol; 2017; 943():119-148. PubMed ID: 27910067
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.
Liang H; Cheung LW; Li J; Ju Z; Yu S; Stemke-Hale K; Dogruluk T; Lu Y; Liu X; Gu C; Guo W; Scherer SE; Carter H; Westin SN; Dyer MD; Verhaak RG; Zhang F; Karchin R; Liu CG; Lu KH; Broaddus RR; Scott KL; Hennessy BT; Mills GB
Genome Res; 2012 Nov; 22(11):2120-9. PubMed ID: 23028188
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
Le Gallo M; Rudd ML; Urick ME; Hansen NF; Zhang S; ; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW
Cancer; 2017 Sep; 123(17):3261-3268. PubMed ID: 28485815
[TBL] [Abstract][Full Text] [Related]
6. Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
Nair N; Camacho-Vanegas O; Rykunov D; Dashkoff M; Camacho SC; Schumacher CA; Irish JC; Harkins TT; Freeman E; Garcia I; Pereira E; Kendall S; Belfer R; Kalir T; Sebra R; Reva B; Dottino P; Martignetti JA
PLoS Med; 2016 Dec; 13(12):e1002206. PubMed ID: 28027320
[TBL] [Abstract][Full Text] [Related]
7. Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.
Peveling-Oberhag J; Wolters F; Döring C; Walter D; Sellmann L; Scholtysik R; Lucioni M; Schubach M; Paulli M; Biskup S; Zeuzem S; Küppers R; Hansmann ML
BMC Cancer; 2015 Oct; 15():773. PubMed ID: 26498442
[TBL] [Abstract][Full Text] [Related]
8. The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.
Gibson WJ; Hoivik EA; Halle MK; Taylor-Weiner A; Cherniack AD; Berg A; Holst F; Zack TI; Werner HM; Staby KM; Rosenberg M; Stefansson IM; Kusonmano K; Chevalier A; Mauland KK; Trovik J; Krakstad C; Giannakis M; Hodis E; Woie K; Bjorge L; Vintermyr OK; Wala JA; Lawrence MS; Getz G; Carter SL; Beroukhim R; Salvesen HB
Nat Genet; 2016 Aug; 48(8):848-55. PubMed ID: 27348297
[TBL] [Abstract][Full Text] [Related]
9. Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks.
Murakami R; Matsumura N; Brown JB; Higasa K; Tsutsumi T; Kamada M; Abou-Taleb H; Hosoe Y; Kitamura S; Yamaguchi K; Abiko K; Hamanishi J; Baba T; Koshiyama M; Okuno Y; Yamada R; Matsuda F; Konishi I; Mandai M
Am J Pathol; 2017 Oct; 187(10):2246-2258. PubMed ID: 28888422
[TBL] [Abstract][Full Text] [Related]
10. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
[TBL] [Abstract][Full Text] [Related]
11. Detection of Molecular Alterations in Taiwanese Patients with Medullary Thyroid Cancer Using Whole-Exome Sequencing.
Chang YS; Chang CC; Huang HY; Lin CY; Yeh KT; Chang JG
Endocr Pathol; 2018 Dec; 29(4):324-331. PubMed ID: 30120715
[TBL] [Abstract][Full Text] [Related]
12. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing to identify novel somatic mutations in squamous cell lung cancers.
Zheng CX; Gu ZH; Han B; Zhang RX; Pan CM; Xiang Y; Rong XJ; Chen X; Li QY; Wan HY
Int J Oncol; 2013 Sep; 43(3):755-64. PubMed ID: 23799614
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling.
Cifola I; Pietrelli A; Consolandi C; Severgnini M; Mangano E; Russo V; De Bellis G; Battaglia C
PLoS One; 2013; 8(5):e63597. PubMed ID: 23704925
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.
Yuan W; Zhang Z; Dai B; Wei Q; Liu J; Liu Y; Liu Y; He L; Zhou D
Cancer; 2016 Jun; 122(11):1689-96. PubMed ID: 26998897
[TBL] [Abstract][Full Text] [Related]
16. Whole exome sequencing in the rat.
Foley JF; Phadke DP; Hardy O; Hardy S; Miller V; Madan A; Howard K; Kruse K; Lord C; Ramaiahgari S; Solomon GG; Shah RR; Pandiri AR; Herbert RA; Sills RC; Merrick BA
BMC Genomics; 2018 Jun; 19(1):487. PubMed ID: 29925311
[TBL] [Abstract][Full Text] [Related]
17. Genomic landscape of endometrial stromal sarcoma of uterus.
Choi YJ; Jung SH; Kim MS; Baek IP; Rhee JK; Lee SH; Hur SY; Kim TM; Chung YJ; Lee SH
Oncotarget; 2015 Oct; 6(32):33319-28. PubMed ID: 26429873
[TBL] [Abstract][Full Text] [Related]
18. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
19. Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.
Pappa KI; Choleza M; Markaki S; Giannikaki E; Kyroudi A; Vlachos G; Voulgaris Z; Anagnou NP
Gynecol Oncol; 2006 Mar; 100(3):596-600. PubMed ID: 16256179
[TBL] [Abstract][Full Text] [Related]
20. Personalized genomic analyses for cancer mutation discovery and interpretation.
Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
